EnCompass Technologies, Inc. — Biomedical Watch V2

Traitements4programmes

Essais2liés

Publications0liées

SourceDBlocale

Traitements

4

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
F2 filter and delivery systemThe goal of this clinical trial is to learn about the safety and performance of the F2 device for cerebral embolic protection in participants with symptomatic aortic stenosis underdoing a Transcatheter Aortic Valve replacement procedure. Participants will complete several neurocognitive assessments and an MRI procedure.	Maladie coronarienne	Non applicable	Traitement symptomatique	United States, Australia	À vérifier
Transcatheter Aortic Valve Replacement (TAVR)The objective of this pivotal study is to compare the safety and effectiveness of the F2 CPC (Treatment group) to a Control group (no embolic protection) in participants undergoing transfemoral (TF) TAVR with commercially available devices.	Maladie coronarienne	Non applicable	À vérifier	United States, Australia	À vérifier
F2 filter and delivery systemThe goal of this clinical trial is to learn about the safety and performance of the F2 device for cerebral embolic protection in participants with symptomatic aortic stenosis underdoing a Transcatheter Aortic Valve replacement procedure. Participants will complete several neurocognitive assessments and an MRI procedure.	Maladie coronarienne	Phase 1	Traitement symptomatique	Georgia	À vérifier
F2 filter and delivery systemThe goal of this clinical trial is to learn about the safety and performance of the F2 device for cerebral embolic protection in participants with symptomatic aortic stenosis underdoing a Transcatheter Aortic Valve replacement procedure. Participants will complete several neurocognitive assessments and an MRI procedure.	Maladie coronarienne	Non applicable	Traitement symptomatique	United States, Australia	À vérifier

Essais cliniques

2

Molécule	Indication / population	Phase	NCT	Titre	Statut
F2 filter and delivery system	Maladie coronarienne	Non applicable	NCT06689839	SHIELD — Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR	RECRUITING
F2 filter and delivery system	Maladie coronarienne	Phase 1	NCT05866640	Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR	COMPLETED

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.